Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
about
The NCI-60 Methylome and Its Integration into CellMiner.Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.PARP Inhibitors in Reproductive System Cancers: Current Use and Developments.Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics.Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer.Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.Unravelling the biology of SCLC: implications for therapy.The Epitranscriptome of Noncoding RNAs in Cancer.The Schlafen family: complex roles in different cell types and virus replication.Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancerEpigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells.Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors.SLFN11 Blocks Stressed Replication Forks Independently of ATR.
P2860
Q30490461-77B753C8-9CC5-455D-A487-C4E0B005F103Q33709790-C31AA0DA-BE82-44E7-9D16-615D5166D8E7Q37607283-CAB54455-0278-4E98-AA1A-B223BB3C5436Q37684589-C3472392-2166-4BB5-AEB7-098DF6F280E9Q37702104-13B6630B-844A-472B-9895-6E13627F2A2EQ38404080-6747D88E-F2DC-4CC2-872E-7530FC4A7AFBQ38632732-F8104F1E-AB25-44D2-9E7B-5AA054E8A407Q38694763-A21E678E-BC83-4072-9D5B-E8BB616AE3A8Q38743845-09B9506B-DA80-4331-BA26-9B738966877AQ38769421-8F45B7D3-E270-4659-BB7C-7D66B8C28B5EQ39188703-CC5B503D-0756-40CA-841B-9E23354CA8B1Q39275728-ED0E6380-DF68-4FA4-8684-C5FF9604530BQ40336402-9B9D6FE1-1ECE-4947-9487-365FB52647D9Q40640808-DD8516B8-6AC1-495B-80AF-38FFBBC53223Q42223681-6AD68C4D-88BE-4167-836E-0B4992A75070Q42281992-3762C6ED-3788-4D4A-A491-B8DB0B0FF915Q47107718-15926A14-2F31-46F8-B78E-8A9B1094D55BQ49390599-F6BC3BCD-094F-4060-8004-E375900BF0B7Q50209876-5C20C70E-43F5-4683-88BA-9B75AFBB85F8
P2860
Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Epigenetic inactivation of the ...... s resistance to platinum drugs
@ast
Epigenetic inactivation of the ...... s resistance to platinum drugs
@en
type
label
Epigenetic inactivation of the ...... s resistance to platinum drugs
@ast
Epigenetic inactivation of the ...... s resistance to platinum drugs
@en
prefLabel
Epigenetic inactivation of the ...... s resistance to platinum drugs
@ast
Epigenetic inactivation of the ...... s resistance to platinum drugs
@en
P2093
P2860
P50
P356
P1433
P1476
Epigenetic inactivation of the ...... s resistance to platinum drugs
@en
P2093
Agusti Barnadas
Anna Martinez-Cardus
Catia Moutinho
P2860
P304
P356
10.18632/ONCOTARGET.6413
P407
P577
2015-11-27T00:00:00Z